XML 24 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaborative Research and Development Agreements, Government Programs and Licenses - Additional Information (Detail) (USD $)
3 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Mar. 31, 2014
Archer Daniels Midland Extension Warrant
Jan. 31, 2013
Archer Daniels Midland Extension Warrant
Mar. 31, 2014
Unilever
T
Jan. 31, 2013
Archer-Daniels-Midland Company
Mar. 31, 2014
Archer-Daniels-Midland Company
Nov. 30, 2012
Collaboration Agreement
T
Feb. 28, 2013
Mitsui & Co., Ltd
Mar. 31, 2014
Department of Energy
Mar. 31, 2013
Department of Energy
Dec. 31, 2013
Department of Energy
Dec. 31, 2009
Department of Energy
Mar. 31, 2014
Minimum
Archer Daniels Midland Extension Warrant
Mar. 31, 2014
Maximum
Archer Daniels Midland Extension Warrant
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                
Supply Commitment Of Oil           10,000                    
Funds awarded to partially fund an integrated biorefinery                           $ 21,800,000    
Company recognized revenues                     0 7,000        
Unbilled revenue 1,706,000   1,101,000               0   0      
Deferred Revenue                     0   0      
Initial production capacity per year                 20,000              
Initial expansion production capacity per year                 40,000              
Expanded production capacity per year                 100,000              
Warrants to purchase number of common stock             500,000                  
Warrant vesting period             5 years                  
Additional warrants to be granted under extension of contract         500,000                      
Warrant measurement date             Jul. 31, 2013                  
Rent expense related to lease 2,600,000 700,000           200,000                
Fair value assumptions, volatility       59.00%                        
Fair value assumptions, risk-free interest rate       1.60%                        
Fair value assumptions, exercise price       $ 7.17                        
Share Price                             $ 10.89 $ 12.97
Fair value assumptions, expected remaining life                             4 years 10 months 24 days 5 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number       41,666       41,666                
Contract amount                   $ 20,000,000